Get the Stockscreener App
3.89
1.57%
0.06
After Hours:
3.93
0.04
+1.03%
Fortress Biotech Inc stock is traded at $3.89, with a volume of 734.25K.
It is up +1.57% in the last 24 hours and up +93.53% over the past month.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
See More
Previous Close:
$3.83
Open:
$3.81
24h Volume:
734.25K
Relative Volume:
1.41
Market Cap:
$115.75M
Revenue:
$80.97M
Net Income/Loss:
$-78.31M
P/E Ratio:
-0.3509
EPS:
-11.0849
Net Cash Flow:
$-129.56M
1W Performance:
+4.85%
1M Performance:
+93.53%
6M Performance:
+124.86%
1Y Performance:
+112.57%
1-Day Range:
$3.72
$3.97
1-Week Range:
$3.26
$3.97
52-Week Range:
$1.325
$3.97
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech Inc
Sector
Industry
Phone
781-652-4500
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
3.89 | 114.85M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-15-24 | Resumed | ROTH MKM | Buy |
| Aug-04-22 | Initiated | Ladenburg Thalmann | Buy |
| Oct-02-20 | Initiated | The Benchmark Company | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Feb-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-22-17 | Initiated | JMP Securities | Mkt Outperform |
| Oct-03-16 | Initiated | ROTH Capital | Buy |
View All
Fortress Biotech Inc Stock (FBIO) Latest News
Is this a good reentry point in Fortress Biotech Inc.2025 Market Sentiment & Daily Profit Focused Screening - Newser
What machine learning models say about Fortress Biotech Inc.Portfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
Tools to assess Fortress Biotech Inc.’s risk profile2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Fortress Biotech (NASDAQ:FBIO) Share Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Volume spikes in Fortress Biotech Inc. stock – what they meanJuly 2025 Movers & Community Verified Swing Trade Signals - Newser
What Fibonacci levels say about Fortress Biotech Inc. reboundM&A Rumor & Weekly High Conviction Ideas - Newser
Has Fortress Biotech Inc. formed a bullish divergenceJuly 2025 Reactions & High Conviction Investment Ideas - Newser
Applying big data sentiment scoring on Fortress Biotech Inc.Weekly Profit Report & Daily Stock Momentum Reports - Newser
Fortress Biotech Inc. stock prediction for this weekMarket Movement Recap & Expert Approved Momentum Ideas - Newser
what fibonacci levels say about fortress biotech inc. reboundDay Trade & Free Verified High Yield Trade Plans - Newser
How to monitor Fortress Biotech Inc. with trend dashboardsJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
Is Fortress Biotech Inc. showing signs of accumulationDividend Hike & Weekly Momentum Picks - Newser
Does Fortress Biotech Inc. fit your quant trading modelEarnings Trend Report & Growth Focused Stock Reports - Newser
Visualizing Fortress Biotech Inc. stock with heatmaps2025 Earnings Surprises & Real-Time Volume Trigger Notifications - Newser
How to manage a losing position in Fortress Biotech Inc.Weekly Volume Report & Safe Entry Point Alerts - Newser
Is Fortress Biotech Inc. building a consolidation baseJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - Newser
Will Fortress Biotech Inc. benefit from macro trendsRisk Management & Verified Technical Signals - Newser
Fortress Biotech, Inc. (NASDAQ:FBIO) Soars 28% But It's A Story Of Risk Vs Reward - 富途牛牛
Is it too late to sell Fortress Biotech Inc.Earnings Recap Report & Low Risk Entry Point Tips - Newser
Using portfolio simulators with Fortress Biotech Inc. included2025 Top Gainers & Community Verified Trade Signals - Newser
Volatility clustering patterns for Fortress Biotech Inc.Watch List & Growth Focused Entry Point Reports - Newser
Fortress Biotech Inc. stock daily chart insightsJuly 2025 Setups & High Yield Equity Trading Tips - Newser
Can Fortress Biotech Inc. hit a new high this monthMarket Trend Review & Safe Capital Preservation Plans - Newser
Using Ichimoku Cloud for Fortress Biotech Inc. technicalsJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Short interest data insights for Fortress Biotech Inc.2025 Retail Activity & Safe Capital Growth Tips - Newser
Will Fortress Biotech Inc. price bounce be sustainableMarket Activity Report & Daily Oversold Bounce Ideas - Newser
Fortress Biotech Inc.’s volatility index tracking explained2025 Price Action Summary & AI Driven Price Predictions - Newser
Fortress Biotech Inc. stock volume spike explained2025 Market Sentiment & Free Community Supported Trade Ideas - Newser
Can you recover from losses in Fortress Biotech Inc.2025 Top Decliners & Verified Stock Trade Ideas - Newser
Real time scanner hits for Fortress Biotech Inc. explainedJobs Report & Community Verified Watchlist Alerts - Newser
Detecting support and resistance levels for Fortress Biotech Inc.Market Growth Summary & Verified Entry Point Signals - Newser
Is This the Dip to Buy in Fortress Biotech Inc.2025 Short Interest & AI Enhanced Trading Signals - beatles.ru
Key metrics from Fortress Biotech Inc.’s quarterly data2025 Biggest Moves & Precise Buy Zone Identification - Newser
Fortress Biotech Inc Stock (FBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):